A key CDC panel meets this week to discuss vaccines. Here’s what to know.

- Advertisement -

This audio is auto-generated. Please let us know if you have feedback.

- Advertisement -

A federal vaccine panel will meet this week for the second time since it was remade by Health and Human Services Secretary Robert F. Kennedy Jr.. Typically a routine affair to update vaccine schedules and issue new recommendations, the committee’s meeting this Thursday and Friday could be particularly consequential for U.S. immunization policy.

Known as the Advisory Committee on Immunization Practices, the panel will meet amid a leadership crisis at the Centers for Disease Control and Prevention and rising alarm among physicians that Kennedy will sharply curtail vaccine access.

Already, Kennedy has overhauled ACIP, firing the 17 prior members of the panel and appointing seven hand-selected advisers in their place. At their first meeting, in June, the new panelists questioned use of COVID-19 vaccines and voted to remove a controversial, but little-used, vaccine preservative from flu shots.

Kennedy’s actions have sparked backlash. The ousted ACIP members have called for creation of an alternative to their former committee, warning of damage to U.S. vaccine policy. Medical groups are pushing back against the CDC and setting their own childhood vaccine recommendations, as several states move forward with plans to decouple their vaccine guidance from the federal schedule. A number of Democratic lawmakers have now called for Kennedy’s resignation, as have hundreds of HHS staff.

Ahead of the meeting on Sept. 18 and 19, here’s what to know:

What’s on the agenda?

A draft agenda released Friday shows this week’s ACIP meeting will focus on vaccines for hepatitis B, COVID, and measles, mumps, rubella and varicella.

Details for each discussion indicate that committee members will hear about seizures following vaccination with the “MMRV” shot, and about use of the hepatitis B vaccine at birth. The panel will vote on recommendations for both immunizations.

All of Friday is set aside for discussion of COVID shots, which have become a flash point in Kennedy’s efforts to upend current vaccine policy. According to The Washington Post,the Trump Administration plans to link the deaths of 25 children to COVID vaccination, potentially as evidence supporting restrictions in access.

In recent statements, COVID vaccine manufacturers Moderna and Pfizer affirmed the safety of their shots. Moderna noted that it’s not aware of any deaths in the last year or new information from past years, while Pfizer detailed the comparative risk of heart inflammation called myocarditis related to its vaccine versus from other causes, like COVID disease itself.

ACIP agendas provide a framework for committee discussion. They reflect months of preparatory work by dozens of CDC staff and scientists, who sift through emerging epidemiological and clinical data to outline vaccine benefits, risks and use.

In the usual course of business, CDC staff, company representatives or other experts provide presentations on vaccines set for discussion.

So who’s on ACIP now?

In June, Kennedy replaced the 17 previously vetted and confirmed ACIP members with eight new advisers he chose, citing unsubstantiated conflicts of interest. One of the eight later decided against participating. Among the seven now serving are vaccine skeptics and physicians whose specialties are in fields other than immunology and epidemiology.

One, MIT business professor and mRNA vaccine critic Retsef Levi, was recently named to lead a revamped COVID working group and will lead several discussions Friday, per the draft agenda.

Ahead of this week’s meeting, Kennedy has apparently been pushing to add more panelists to the smaller-than-usual roster.

Physician Jeremy Faust, in his Substack publication Inside Medicine, reported Sept. 3 on seven potential new members, including individuals whose backgrounds are atypical for ACIP.

It’s not clear how those individuals were vetted, or whether they have even been officially nominated to the panel.

Source link

- Advertisement -

Advertisement

Google Parent Alphabet’s Market...

Google parent Alphabet’s market value just reached a...

GOP amps up pressure...

NEWYou can now listen to Fox News articles! ...